View PubMed Publications
Dixon S, Lane A, O’Brien MO, Burns KC, Mangino JL, Breese EH,Absalon M, Perentesis JP, Phillips CL. Viral surveillance using PCR during treatment of AML and ALL. Pediatric Blood and Cancer. 2017.
Fouladi M, Perentesis JP, Phillips CL, Leary S, Reid JM, McGovern, R, Ingle AM, Ahern CH, Ames MM, Houghton P, Doyle LA, Weigel B, Blaney SM. A phase I trial of MK-2206 in children with refractory malignancies: A Children’s Oncology Group Study. Pediatr Blood Cancer. 2014 Jul;61(7):1246-51.
Phillips CL, Davies SM, McMasters R, Absalon M, O’Brien M, Mo J, Broun R, Moscow JA, Smolarek T, Garzon R, Blum W, Schwind, Marcucci G, Perentesis JP. Low dose decitabine in very high risk relapsed or refractory acute myeloid leukemia in children and young adults. British Journal of Haematology. 2013;161(3):406-10.
Phillips CL, Miles L, Jones BV, Sutton M, Crone K, Fouladi M. Medulloblastoma with melanotic differentiation: Case report and review of the literature. J Neurooncol. 2011 Jul;103(3):759-64.
Phillips CL, Gerbing R, Alonzo T, Perentesis JP, Harley ITW, Meshinchi S, Bhatla D, Radloff G, Davies SM. MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia. Pediatr Blood Cancer. 2010 Aug;55(2):248-53.